Bausch Health Archives - Kybora

首页
关于我们
我们的服务
最新发布
联系我们
中文
- English
- 中文

首页
关于我们
我们的服务
最新发布
联系我们
中文
- English
- 中文

KYBORA successfully helps Stada license Xlucane to Bausch Health

6 5 月, 2020

Comments are off for this post.

News

KYBORA successfully helps Stada license Xlucane to Bausch Health

KYBORA is pleased to announce that it has successfully […]

Recent blog post.

KYBORA Welcomes Vladyslava Bab’yak as an Analyst

Posted: 1 周 ago
Podcast: Healthcare Insights by KYBORA

Posted: 1 周 ago
RODIM Reaches Key Milestones in 2024 Through Strategic Partnership with KYBORA and BPEACE

Posted: 3 周 ago
Top 10 Challenges Facing CEOs of Biotech Startups and Small/Mid-Sized Biotechs in a Post-2022 World

Posted: 4 周 ago
KYBORA Welcomes Erik Heinnickel as Senior Director of Operations

Posted: 1 月 ago

Tags.

#biopharma Licensing Announcement Bausch Health biopharma biotechnology China Conference Corporate globalhealthcare healthtech Kybora Team LIcensing March 2020 mergersandacquisitions News Priority List Stada license

我们期待听取您关于业务拓展的需求

KYBORA是一家聚焦创新医药和医疗器械领域的全球化顾问公司。她以帮助客户拓展全球业务并取得卓越业绩为使命，为遍布世界各地的客户提供包括全球产权交易、融资、收并购、资源对接及高端战略咨询在内的优质服务。

关于我们.

关于开博锐
核心团队
成功案例
全球驻地

我们的服务.

收并购
产权交易
融资
战略咨询

最新发布.

KYBORA Welcomes Vladyslava Bab’yak as an Analyst

Posted: 1 周 ago
Podcast: Healthcare Insights by KYBORA

Posted: 1 周 ago

© KYBORA All Rights Reserved.

Terms of service | Privacy policy

TYPE & ENTER: